Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Solventum Corp
Bryan C. Hanson, an executive at Solventum Corp, reported a change in beneficial ownership of company securities effective September 1, 2026. This filing serves as an official disclosure of the insider's equity holdings.…more
Solventum Corp
Insider Neil Craig Zieselman of Solventum Corp reported a change in beneficial ownership of company securities on August 17, 2026. This Form 4 filing officially discloses the changes in the executive's shareholdings and equity structure.…more
Solventum Corp
Solventum Corp has filed a Limited Power of Attorney for Neil Zielselman. This document formally authorizes the designated attorney-in-fact to sign and file company-related documents on its behalf.…more
5 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Solventum Receives FDA Clearance for Combined Wound Healing Solution
Solventum has received FDA 510(k) clearance for the combined use of its Restrata fiber matrix and V.A.C. Therapy. This regulatory milestone allows the company to integrate two advanced technologies into a single path for active wound healing.…more
●●●●●●●● ●●●●● ●●●●●●
Solvac은 2026년 상반기 세후 이익 9,640만 유로를 기록하며 전년 동기와 유사한 안정적인 실적을 유지했습니다. 회사는 기존 배당 정책에 따라 주당 2.905유로의 중간 배당을 8월 31일에 지급하기로 결정했습니다.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.